The financial performance of Abbott Laboratories (NYSE: ABT) has been positively impacted by the high demand for COVID-related diagnostic services. However, in
Categories
Medical Devices
Medtronic (MDT) goes the extra mile to emerge stronger from virus crisis
The pandemic has influenced the healthcare industry significantly, but not all the segments are impacted in the same way. While hospitals and
Medtronic plc (MDT) Q3 2021 Earnings Call Transcript
Medtronic plc (NYSE: MDT) Q3 2021 earnings call dated Feb. 23, 2021 Corporate Participants: Ryan Weispfenning -- Vice President, Head of Investor Relations Geoffrey
Medtronic’s revenues inch up in Q3: Infographic
Medtronic (NYSE: MDT) reported third-quarter 2021 financial results before the regular market hours on Tuesday. The medical equipment company posted third-quarter revenue
Infographic: Intuitive Surgical Q4 earnings results
Intuitive Surgical (NASDAQ: ISRG) reported fourth-quarter 2020 financial results after the regular market hours on Thursday. The robotic product's manufacturer reported fourth-quarter
AdaptHealth (AHCO) gains on AeroCare acquisition announcement
Shares of AdaptHealth Corp. (NASDAQ: AHCO) surged 15% in morning trade on Tuesday after the company announced its decision to acquire privately-held
Medtronic PLC (MDT) Q2 2021 Earnings Call Transcript
Medtronic PLC (NYSE: MDT) Q2 2021 earnings call dated Nov. 24, 2020 Corporate Participants: Ryan Weispfenning -- Vice President - Head of Investor Relations
Infographic: How Medtronic (MDT) performed in Q2 financial results
Medtronic plc (NYSE: MDT) reported second quarter 2021 earnings results today. Worldwide revenue was $7.64 billion, down 0.8% on a reported basis
Beyond Air (XAIR) has hopes pinned on these two product opportunities for next year
Shares of Beyond Air Inc. (NASDAQ: XAIR) gained over 3% in midday trade on Thursday. The stock has climbed 5% since the
Beyond Air, Inc. (XAIR) Q2 2021 Earnings Call Transcript
Beyond Air, Inc. (NASDAQ: XAIR) Q2 2021 earnings call dated Nov. 11, 2020 Corporate Participants: Maria Yonkoski -- Head of Investor Relations Steve Lisi -- Chief
Cardinal Health Inc. (CAH) Q1 2021 Earnings Call Transcript
Cardinal Health Inc. (NYSE: CAH) Q1 2021 earnings call dated Nov. 05, 2020 Corporate Participants: Kevin Moran -- Vice President, Investor Relations Mike Kaufmann -- Chief
Edwards Lifesciences Corp (EW) Q3 2020 Earnings Call Transcript
Edwards Lifesciences Corp (NYSE: EW) Q3 2020 earnings call dated Oct. 21, 2020 Corporate Participants: Mark Wilterding -- Investor Relations Michael A. Mussallem -- Chairman and
Align Technology Inc. (ALGN) Q3 2020 Earnings Call Transcript
Align Technology Inc (NASDAQ: ALGN) Q3 2020 earnings call dated Oct. 21, 2020 Corporate Participants: Shirley Stacy -- Vice President - Finance, Corporate and
Abbott Laboratories (ABT) Q3 2020 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q3 2020 earnings call dated Oct. 21, 2020 Corporate Participants: Scott Leinenweber -- Vice President of Investor Relations, Licensing and
ABT Earnings: Key numbers from Abbott Laboratories Q3 financial results
Abbott (NYSE: ABT) today announced its third quarter financial results for the period ended September 30, 2020. Net earnings for the third
Thermo Fisher Scientific (TMO) Earnings: 3Q20 Key Numbers
Thermo Fisher Scientific Inc. (NYSE: TMO) reported third quarter 2020 earnings results today. Revenue increased 36% year-over-year to $8.52 billion. GAAP earnings
Intuitive Surgical Inc. (ISRG) Q3 2020 Earnings Call Transcript
Intuitive Surgical Inc (NASDAQ: ISRG) Q3 2020 earnings call dated Oct. 15, 2020 Corporate Participants: Philip Kim -- Head of Investor Relations Gary S.
Earnings: Intuitive Surgical (ISRG) Q3 results exceed estimates
Intuitive Surgical Inc. (NASDAQ: ISRG) reported lower earnings and revenues for the third quarter of 2020, hurt by the coronavirus-related disruption. However,
Johnson & Johnson (JNJ) Q3 2020 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q3 2020 earnings call dated Oct. 13, 2020 Corporate Participants: Christopher DelOrefice -- Vice President of Investor Relations Joseph
AngioDynamics Inc. (ANGO) Q1 2021 Earnings Call Transcript
AngioDynamics Inc. (NASDAQ: ANGO) Q1 2021 earnings call dated Sep. 29, 2020 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
Key highlights from AngioDynamics (ANGO) Q1 2021 earnings results
AngioDynamics Inc. (NASDAQ: ANGO) reported first quarter 2021 earnings results today. Net sales increased 6.3% to $70.2 million but were impacted by